{Reference Type}: Journal Article
{Title}: COVID-19 Vaccine Hesitancy: Umbrella Review of Systematic Reviews and Meta-Analysis.
{Author}: Rahbeni TA;Satapathy P;Itumalla R;Marzo RR;Mugheed KAL;Khatib MN;Gaidhane S;Zahiruddin QS;Rabaan AA;Alrasheed HA;Al-Subaie MF;Al Kaabil NA;Alissa M;Ibrahim AAAL;Alsaif HA;Naser IH;Rustagi S;Kukreti N;Dziedzic A;
{Journal}: JMIR Public Health Surveill
{Volume}: 10
{Issue}: 0
{Year}: 2024 Apr 30
{Factor}: 14.557
{DOI}: 10.2196/54769
{Abstract}: <B>BACKGROUND: </B>The unprecedented emergence of the COVID-19 pandemic necessitated the development and global distribution of vaccines, making the understanding of global vaccine acceptance and hesitancy crucial to overcoming barriers to vaccination and achieving widespread immunization.<BR><B>OBJECTIVE: </B>This umbrella review synthesizes findings from systematic reviews and meta-analyses to provide insights into global perceptions on COVID-19 vaccine acceptance and hesitancy across diverse populations and regions.<BR><B>METHODS: </B>We conducted a literature search across major databases to identify systematic reviews and meta-analysis that reported COVID-19 vaccine acceptance and hesitancy. The AMSTAR-2 (A Measurement Tool to Assess Systematic Reviews) criteria were used to assess the methodological quality of included systematic reviews. Meta-analysis was performed using STATA 17 with a random effect model. The data synthesis is presented in a table format and via a narrative.<BR><B>RESULTS: </B>Our inclusion criteria were met by 78 meta-analyses published between 2021 and 2023. Our analysis revealed a moderate vaccine acceptance rate of 63% (95% CI 0.60%-0.67%) in the general population, with significant heterogeneity (I2 = 97.59%). Higher acceptance rates were observed among health care workers and individuals with chronic diseases, at 64% (95% CI 0.57%-0.71%) and 69% (95% CI 0.61%-0.76%), respectively. However, lower acceptance was noted among pregnant women, at 48% (95% CI 0.42%-0.53%), and parents consenting for their children, at 61.29% (95% CI 0.56%-0.67%). The pooled vaccine hesitancy rate was 32% (95% CI 0.25%-0.39%) in the general population. The quality assessment revealed 19 high-quality, 38 moderate-quality, 15 low-quality, and 6 critically low-quality meta-analyses.<BR><B>CONCLUSIONS: </B>This review revealed the presence of vaccine hesitancy globally, emphasizing the necessity for population-specific, culturally sensitive interventions and clear, credible information dissemination to foster vaccine acceptance. The observed disparities accentuate the need for continuous research to understand evolving vaccine perceptions and to address the unique concerns and needs of diverse populations, thereby aiding in the formulation of effective and inclusive vaccination strategies.<BR><B>BACKGROUND: </B>PROSPERO CRD42023468363; https://tinyurl.com/2p9kv9cr.